Parallax Volatility Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Parallax Volatility Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-48	Closed	-$1.69K	–	3012
2023 Q1	$1.17K	Buy	+48	New	+$1.05K	﹤0.01%	2598
2022 Q4	–	Sell	-6,973	Closed	-$125K	–	3413
2022 Q3	$125K	Sell	6,973 -95,080	-93%	-$1.25M	﹤0.01%	2428
2022 Q2	$982K	Buy	+102,053	New	+$1.28M	﹤0.01%	1653
2021 Q4	–	Sell	-25,927	Closed	-$421K	–	2440
2021 Q3	$421K	Buy	+25,927	New	+$282K	﹤0.01%	1546
2016 Q3	–	Sell	-6,437	Closed	-$363K	–	4164
2016 Q2	$328K	Buy	+6,437	New	+$320K	﹤0.01%	1625

Parallax Volatility Advisers's ISEE Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 48 shares — an estimated $1.69K sold.

Parallax Volatility Advisers first reported a position in ISEE in Q2 2016 and held it in 5 quarters. The position peaked at $982K in Q2 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Parallax Volatility Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 48 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.69K.
Parallax Volatility Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 5 quarters.
Parallax Volatility Advisers's IVERIC bio, Inc. Common Stock position peaked at $982K in Q2 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.